Ind-Swift Laboratories Limited (INDSWFTLAB)
Outcome of Board Meeting
Q1FY27 results (unaudited):
Standalone:
Revenue 18.6bn +21% y-y (15.4bn)
EBITDA 3.3bn
PAT 2.44bn +201% y-y (0.81bn)
Consolidated:
Revenue 19.9bn +19% y-y (16.7bn)
PAT 2.47bn +181% y-y (0.88bn)
Dividend: Not declared
Commentary: Exceptional items include Rs 23.58 Lakhs for the quarter related to balances written back/written off (net) on account of amounts no longer payable/receivable.
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 INDSWFTLAB — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add INDSWFTLAB to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Ind-Swift Laboratories Limited
Important.
The summary above is generated automatically from Ind-Swift Laboratories Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.